Zeynep ORUC, Muhammet Ali KAPLAN, Abdurrahman ISİKDOGAN

Changes in medical oncology practice due to the COVID-19 pandemic in Turkey, and the risk of neglect of cancer patients

Cancer patients are among patient groups most affected by the COVID-19 outbreak. During the COVID-19 pandemic, rearrangement of oncological services and adaptation to the pandemic process has become mandatory. In this review, we mentioned the changes in medical oncology practice and adaptive treatment modifications. COVID-19 infection will continue to affect and change the practice of oncology unless the COVID-19 outbreak ends.

Keywords:

COVID-19 pandemia, oncology, cancer patients,

PDF

___

1. Kuderer NM, Choueiri TK, Shah DP, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241): 1907-18.
2. Dai M, Liu D, Liu M, et al. Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak. Cancer Discov. 2020;10(6):783-791.
3. Ofori-Asenso R, Ogundipe O, Agyeman AA, et al. Cancer is associated with severe disease in COVID- 19 patients: a systematic review and meta-analysis. Ecancermedicalscience. 2020 May 18;14:1047.
4. Lewis MA. Between Scylla and Charybdis - Oncologic Decision Making in the Time of Covid-19. N Engl J Med. 2020; 382: 2285-7.
5. IQVIA. Shifts in healthcare demand, delivery and care during the COVID-19 era (2020). www.iqvia.com/insights/the-iqvia-institute/covid- 19/shif ts-in-healthcare-demand-delivery-andcare- during-the-covid-19-era.
6. Kurt İnci B, Gürler F, Özet A. Pandemi sürecinde kanser tanı, tedavi, takibinde karşılaşılacak sorunlar ve muhtemel değişiklikler. Yalçın Ş, Özet A, editörler. Kanserve COVID-19 Pandemisi. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.69-73.
7. Gasparri ML, Gentilini OD, Lueftner D, et al. Changes in breast cancer management during the Corona Virus Disease 19 pandemic: An international survey of the European Breast Cancer Research Association of Surgical Trialists (EUBREAST). Breast. 2020;52:110-115. doi:10.1016/j.breast.2020.05.006.
8. Karacin C, Bilgetekin I, B Basal F, et al. How does COVID-19 fear and anxiety affect chemotherapy adherence in patients with cancer [published online ahead of print, 2020 Jul 17]. Future Oncol. 2020;10.2217/fon-2020-0592. doi:10.2217/fon- 2020-0592.
9. Sutcuoglu O, Yazici O, Ozet A, Ozdemir N. Harmful consequences of COVID-19 fear in patients with cancer. [ Epub ahead of print. 2020 Dec 21]. BMJ Support Palliat Care.2020; bmjspcare-2020- 002628.doi: 10.1136/bmjspcare-2020-002628.
10. Guven DC, Aktas BY, Aksun MS, et al. COVID-19 pandemic: changes in cancer admissions [published online ahead of print, 2020 Jul 14]. BMJ Support Palliat Care. 2020; bmjspcare-2020-002468. doi:10.1136/bmjspcare-2020-002468.
11. European Society of Medical Oncology (ESMO). Cancer Patient Management During The COVID-19 Pandemic. Available at https://www. esmo.org/guidelines/cancer-patient-managementduring- the-covid-19-pandemic. Accessed April 10, 2020.
12. American Society of Clinical Oncology (ASCO). COVID-19 Patient Care Information. Available at https://www.asco.org/asco-coronavirus-informati on/care-individuals-cancer-during-covid-19. Accessed April 10, 2020.
13. The National Comprehensive Cancer Network (NCCN). Coronavirus Disease 2019 (COVID-19) Resources for the Cancer Care Community. Available at https://www.nccn.org/
14. Ahmet Taner SÜMBÜL, Şuayip YALÇIN, et al. Turkish Medical Oncology Society COVID-19 Pandemic Advisory Board Recommendations for Cancer Patients and Medical Oncologist.JOncol Sci. 2020; 6:1-4.
15. Yalçın Ş, Çılbır E, Karadurmuş N,et al. COVID-19 pandemisidönemindetıbbionkolojidekanserlihastay ayaklaşımilkeleri. Yalçın Ş, Özet A, editörler. Kanserve COVID-19 Pandemisi. 1. Baskı. Ankara: TürkiyeKlinikleri; 2020. p.45-9.
16. Al-Shamsi HO, Alhazzani W, Alhuraiji A, et al. A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020; 25: e936- e945. doi:10.1634/theoncologist.2020-0213.
17. Bersanelli M. Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy. 2020. https://doi.org/10.2217/imt-2020-0067.
18. Leora Horn, Jennifer G. Whisenant, ValterTorri, et al. Thoracic Cancers International COVID-19 Collaboration (TERAVOLT): Impact of type of cancer therapy and COVID therapy on survival. J ClinOncol 38: 2020 (suppl; abstr LBA111) doi: 10.1200/JCO.2020.38.18_suppl.LBA111.
19. KaracaYayla B, Göker E. Cilttümörlerive COVID- 19: Pandemisürecindekanserhastalarınınihmaledilmesi riski. Yalçın Ş, Özet A, editörler. Kanserve COVID-19 Pandemisi. 1. Baskı. Ankara: TürkiyeKlinikleri; 2020. p.174-6.
20. Ueda M, Martins R, Hendrie PC, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal [published online ahead of print, 2020 Mar 20]. J Natl ComprCancNetw. 2020;1-4. doi:10.6004/jnccn.2020.7560.